J. Goldman & Co’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

J. Goldman & Co’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-300,000	Closed	-$2.89M	–	508
2021 Q2	$2.9M	Buy	+300,000	New	+$2.93M	0.11%	196

J. Goldman & Co's MSAC Position: Q3 2021 in Review

J. Goldman & Co sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q3 2021, closing a stake of 300,000 shares — an estimated $2.89M sold.

J. Goldman & Co first reported a position in MSAC in Q2 2021 and held it in 1 quarter. The position peaked at $2.9M in Q2 2021. 46 funds tracked by Wall St. Rank hold MSAC as of Q3 2021.

J. Goldman & Co reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q3 2021 after selling out during the quarter.
J. Goldman & Co sold 300,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q3 2021, an estimated $2.89M.
J. Goldman & Co first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 1 quarter.
J. Goldman & Co's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $2.9M in Q2 2021.
46 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q3 2021.

Based on J. Goldman & Co's 13F filing for Q3 2021, filed 15 Nov 2021.